TAYLOR KUE: Open Payments
NPI 1326751348 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,386 in 52 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $785 · 2025 $1,386
Food & beverage: $1,314Education: $72
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $357 |
| Galderma Laboratories, L.P. | 7 | $286 |
| LEO Pharma Inc. | 9 | $226 |
| Janssen Biotech, Inc. | 6 | $206 |
| Regeneron Healthcare Solutions, Inc. | 4 | $180 |
| Organon LLC | 3 | $44 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $35 |
| Amgen Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
| GENZYME CORPORATION | 1 | $14 |
Products named: NEMLUVIO, COSENTYX, TREMFYA, DUPIXENT, ADBRY, Rhapsido, VTAMA, ANZUPGO.
Industry payments across RI — which companies pay providers there.
